United States · FDA National Drug Code directory
Lithium Carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-221_02893f26-d53b-43c9-81bf-100a9dce33a4
- Product NDC
- 68462-221
- Form
- CAPSULE
- Composition / generic term
- Lithium Carbonate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090203
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68462-221-01) · 68462-221-01
- 1000 CAPSULE in 1 BOTTLE (68462-221-10) · 68462-221-10
- 10 BLISTER PACK in 1 CARTON (68462-221-11) / 10 CAPSULE in 1 BLISTER PACK · 68462-221-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →